Skip to main content

Table 3 Complementary analyses: Medical resource utilization and prescribed medications in 2008 in the 3 subgroups identified within the high-ICS-ratio group

From: Prescribed therapy for asthma: therapeutic ratios and outcomes

  50% ≤ R < 60% 60% ≤ R < 90% 90% ≤ R p-value
UK
Number of patients 10,929 3,715 2,094  
Number of respiratory medication prescriptions (mean) 7.5 6.86 3.62 <0.0001
Systemic corticosteroids     
Patients with ≥ 1 prescription (%) 12.7% 14.7% 8.9% <0.0001
Number of prescriptions (mean) 0.2 0.24 0.16 0.0006
Antibiotics (a)     
Patients with ≥ 1 prescription (%) 41.9% 43.4% 35.5% <0.0001
Number of prescriptions (mean) 0.8 0.86 0.7 0.0001
Patients with ≥ 1 prescription of LABA-ICS fixed combination (%) 38.9% 56.2% 51% <0.0001
Number of GP visits (mean) 6.5 7.2 5.9 <0.0001
France (b)
Number of patients 783 597 673  
Number of respiratory medication prescriptions units (mean) 9.61 11 5.67 <0.0001
Systemic corticosteroids     
Patients with ≥ 1 prescription (%) 29.9% 33.3% 28.7% 0.178
Number of units (b) (mean) 0.84 0.82 0.77 0.811
Antibiotics (a)     
Patients with ≥ 1 prescription (%) 50.7% 55.8% 53.3% 0.17
Number of units (b) (mean) 1.61 1.91 1.52 0.0159
Patients with ≥ 1 prescription of LABA-ICS fixed combination (%) 75.5% 89.9% 82% <0.0001
Number of GP visits (mean) 5.4 5.8 5.6 0.273
  1. (a)Beta-lactams, cephalosporins (first to third generations), macrolides and fluoroquinolones.
  2. (b)Canisters for inhaled therapy and packages for oral therapy.